Clinical documentation

Ongoing studies

Pain evaluation in radium-223 treated castration resistant prostate cancer patients with bone metastases (PARABO)

Germany | Read more (external link)

A biomarker study of standard-of-care radium-223 chloride for metastatic castration-resistant prostate cancer

USA | Read more (external link)

A phase IIb study to evaluate efficacy and tolerability of ODX (Osteodex) in metastatic CRPC

Sweden, Denmark | Read more (external link)

Trial of abiraterone acetate plus LHRH-therapy versus abiraterone acetate sparing LHRH-therapy in patients with progressive chemotherapy-naïve castration-resistant prostate cancer (SPARE)

Germany | Read more (external link)

Evaluation of therapeutic effect on prostate cancer patients with bone metastases using Bone Scan Index (BSI)

Japan | Read more (external link)